Bridgewater Associates LP reduced its holdings in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 44.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 15,999 shares of the company's stock after selling 12,959 shares during the period. Bridgewater Associates LP's holdings in Molina Healthcare were worth $5,513,000 as of its most recent SEC filing.
Several other hedge funds have also recently made changes to their positions in MOH. Renaissance Technologies LLC lifted its position in Molina Healthcare by 13.3% in the 2nd quarter. Renaissance Technologies LLC now owns 949,691 shares of the company's stock valued at $282,343,000 after acquiring an additional 111,154 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Molina Healthcare by 22.0% in the second quarter. Dimensional Fund Advisors LP now owns 470,932 shares of the company's stock valued at $140,026,000 after purchasing an additional 84,929 shares in the last quarter. AQR Capital Management LLC boosted its position in shares of Molina Healthcare by 36.2% during the second quarter. AQR Capital Management LLC now owns 463,537 shares of the company's stock valued at $137,810,000 after buying an additional 123,121 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in Molina Healthcare by 2.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 390,078 shares of the company's stock worth $134,405,000 after buying an additional 10,030 shares in the last quarter. Finally, TD Asset Management Inc grew its holdings in Molina Healthcare by 9.5% during the second quarter. TD Asset Management Inc now owns 270,996 shares of the company's stock worth $80,567,000 after buying an additional 23,533 shares in the last quarter. 98.50% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
MOH has been the topic of several recent analyst reports. Cantor Fitzgerald restated an "overweight" rating and set a $406.00 price objective on shares of Molina Healthcare in a research note on Thursday, October 24th. Wells Fargo & Company raised their price target on shares of Molina Healthcare from $360.00 to $362.00 and gave the company an "equal weight" rating in a research report on Monday, November 4th. StockNews.com raised shares of Molina Healthcare from a "hold" rating to a "buy" rating in a research report on Friday, October 18th. Robert W. Baird decreased their price objective on shares of Molina Healthcare from $405.00 to $331.00 and set an "outperform" rating for the company in a research note on Thursday, October 24th. Finally, Barclays boosted their target price on Molina Healthcare from $359.00 to $372.00 and gave the stock an "equal weight" rating in a research note on Friday, October 25th. One analyst has rated the stock with a sell rating, six have issued a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $367.17.
Check Out Our Latest Report on Molina Healthcare
Molina Healthcare Stock Performance
NYSE MOH traded up $1.30 on Friday, hitting $297.90. 267,142 shares of the stock traded hands, compared to its average volume of 545,797. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.55 and a current ratio of 1.54. The business's fifty day moving average is $317.40 and its two-hundred day moving average is $322.00. Molina Healthcare, Inc. has a 12 month low of $272.69 and a 12 month high of $423.92. The firm has a market capitalization of $17.04 billion, a price-to-earnings ratio of 15.13, a PEG ratio of 1.02 and a beta of 0.59.
Molina Healthcare (NYSE:MOH - Get Free Report) last posted its quarterly earnings results on Wednesday, October 23rd. The company reported $6.01 earnings per share for the quarter, topping the consensus estimate of $5.96 by $0.05. Molina Healthcare had a return on equity of 27.88% and a net margin of 2.92%. The company had revenue of $10.34 billion during the quarter, compared to the consensus estimate of $9.92 billion. During the same quarter in the prior year, the company earned $5.05 EPS. The firm's quarterly revenue was up 21.0% compared to the same quarter last year. As a group, equities analysts anticipate that Molina Healthcare, Inc. will post 23.44 EPS for the current fiscal year.
About Molina Healthcare
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Stories
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.